Breaking News Instant updates and real-time market news.

ZM

Zoom Video

$91.83

0.41 (0.45%)

, WORK

Slack Technologies

$34.27

-0.73 (-2.09%)

10:14
07/12/19
07/12
10:14
07/12/19
10:14

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Slack Technologies (WORK) and Zoom Video (ZM) were initiated with an Overweight at Stephens. 2. Fate Therapeutics (FATE) initiated with an Outperform at Oppenheimer. 3. Ameris Bancorp (ABCB) initiated with an Outperform at Raymond James. 4. TriCo Bancshares (TCBK) initiated with a Neutral at Piper Jaffray. 5. Axalta Coating (AXTA) initiated with a Buy at Berenberg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ZM

Zoom Video

$91.83

0.41 (0.45%)

WORK

Slack Technologies

$34.27

-0.73 (-2.09%)

FATE

Fate Therapeutics

$21.45

1.05 (5.15%)

ABCB

Ameris Bancorp

$38.74

0.17 (0.44%)

TCBK

TriCo Bancshares

$38.52

0.41 (1.08%)

AXTA

Axalta Coating

$29.40

0.01 (0.03%)

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 09

    Sep

  • 23

    Sep

ZM Zoom Video
$91.83

0.41 (0.45%)

07/12/19
WBLR
07/12/19
NO CHANGE
WBLR
Zoom Video growth still in 'early innings,' says William Blair
William Blair analyst Bhavan Suri says he left meeting with Zoom Video Communications' head of investor relations with reinforced confidence in the company's positioning and ability to continue gaining share in the market. Zoom is benefiting from a secular shift to video communications, which is still in the "early innings," Suri tells investors in a research note. He believes Zoom's "robust" growth and "best-in-class" operating metrics should continue "for years to come." The analyst keeps an Outperform rating on the shares.
07/01/19
GSCO
07/01/19
DOWNGRADE
Target $66
GSCO
Sell
Zoom Video downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Heather Bellini last night downgraded Zoom Video Communications (ZM) to Sell from Neutral while raising her price target for the shares to $66 from $53. The stock closed Friday down $1.48 to $88.79. The analyst says her "blue sky scenario" is already more than factored into investor expectations at current valuation levels. Bellini, however, adds that her view on Zoom Video's ability to continue to execute well and exceed consensus expectations remains unchanged. Nonetheless, the potential for long-term performance is well understood by the market, contends the analyst. Bellini last night also downgraded SolarWinds (SWI) to Sell from Neutral and upgraded Anaplan (PLAN) to Buy from Neutral.
07/01/19
07/01/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. SolarWinds (SWI) downgraded to Sell from Neutral at Goldman Sachs with analyst Heather Bellini saying while the company's valuation, on an absolute basis, does not appear "overly expensive," the shares have "limited possibility" for multiple expansion given its end market exposure and already best in class operating margins. 2. SM Energy (SM) downgraded to Underweight from Equal Weight at Barclays with analyst William Thompson saying while the company's high leverage provides "oil beta with arguably premier Midland acreage," continuous drilling obligations could restrict it from pivoting away from the Eagle Ford condensate. 3. Zoom Video (ZM) downgraded to Sell from Neutral at Goldman Sachs with analyst Heather Bellini saying her "blue sky scenario" is already more than factored into investor expectations at current valuation levels. 4. Carnival (CCL) downgraded to Hold from Buy at Berenberg with analyst Stuart Gordon saying the company appears to be "finely balanced between a deteriorating operating performance and a cheap valuation." 5. Yum! Brands (YUM) downgraded to Underperform from Neutral at Longbow with analyst Alton Stump saying the stock is trading at nearly a 25% premium to its closest quick-service peers despite similar comp growth, unit growth and leverage. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/19
SPHN
07/11/19
INITIATION
Target $115
SPHN
Overweight
Zoom Video initiated with an Overweight at Stephens
Stephens analyst Dmitry Netis initiated Zoom Video with an Overweight rating and $115 price target, citing his view that Zoom's modern approach to video "is driving a fundamental change in the user consumption model." He also believes continued share gains, new product launches, growing penetration and international expansion give Zoom a long growth runway.
WORK Slack Technologies
$34.27

-0.73 (-2.09%)

07/09/19
07/09/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chewy (CHWY) was initiated with an Outperform at William Blair and Wells Fargo, an Overweight at JPMorgan, a Buy at BofA/Merrill and UBS, an Equal Weight at Morgan Stanley and Barclays, a Market Perform at Raymond James, a Sector Perform at RBC Capital, a Hold at Jefferies, and a Neutral at Nomura Instinet. 2. Intellia Therapeutics (NTLA) initiated with an Outperform at Baird. 3. Slack Technologies (WORK) initiated with a Perform at Oppenheimer. 4. AAR Corp. (AIR) initiated with a Buy at Stifel. 5. Vista Outdoor (VSTO) initiated with a Buy at Lake Street. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/19
SPHN
07/11/19
INITIATION
Target $43
SPHN
Overweight
Slack Technologies initiated with an Overweight at Stephens
Stephens analyst Dmitry Netis initiated Slack Technologies with an Overweight rating and $43 price target, citing his view that the company has a long runway to penetrate enterprises globally, convert its freemium customer base to paid use and launch new products. He also believes Slack's viral adoption and large enterprise go-to-market effort will drive additional customers and higher ARPU.
07/08/19
OPCO
07/08/19
INITIATION
OPCO
Perform
Slack Technologies initiated with a Perform at Oppenheimer
Oppenheimer analyst Ittai Kidron initiated Slack Technologies with a Perform rating.
07/09/19
07/09/19
INITIATION

Perform
Slack Technologies initiated with a Perform on valuation at Oppenheimer
As previously reported, Oppenheimer analyst Ittai Kidron started coverage of Slack Technologies with a Perform rating. While the analyst acknowledged Slack's differentiated platform, expectations for share gains/TAM expansion within the CA market, and strong land-and-expand execution that combines viral, self-service user expansion with a successful top-down enterprise sales motion, he believes the upside is baked into the shares and would rather wait for a better entry point.
FATE Fate Therapeutics
$21.45

1.05 (5.15%)

06/27/19
PIPR
06/27/19
NO CHANGE
Target $30
PIPR
Overweight
Fate Therapeutics price target raised to $30 from $23 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Fate Therapeutics to $30 from $23 saying the company remains a top pick for the second half of 2019 given its "first-in-class iPSC cancer cell pipeline." The analyst reiterates an Overweight rating on the shares.
07/12/19
OPCO
07/12/19
INITIATION
Target $27
OPCO
Outperform
Fate's iPSC technology could disrupt cancer cell therapy field, says Oppenheimer
Oppenheimer analyst Matthew Biegler initiated Fate Therapeutics with an Outperform rating and $27 price target. In a research note to investors, Biegler says he believes Fate's induced pluripotent stem cell technology could fundamentally disrupt the emerging field of cancer cell therapy, and feels the iPSC platform could serve as a renewable and efficient source of off-the-shelf genetically engineered T and NK cell therapies. Biegler says he views the next 12-18 months as potentially transformative for Fate, as it advances several iPSC-derived therapies into clinical trials.
07/11/19
OPCO
07/11/19
INITIATION
Target $27
OPCO
Outperform
Fate Therapeutics initiated with an Outperform at Oppenheimer
Oppenheimer initiated Fate Therapeutics with an Outperform rating and $27 price target.
06/27/19
PIPR
06/27/19
NO CHANGE
PIPR
Piper keeps Crispr, Fate as top picks for 2019, adds Arvinas
Piper Jaffray analyst Edward Tenthoff revisited his top picks Biotechnology picks into the second half of 2019, including Crispr Therapeutics (CRSP) and Fate Therapeutics (FATE), and he added Arvinas (ARVN). ). For Crispr, he anticipates first-in-man CTX001 data in transfusion-dependent beta thalassemia patients likely in December to serve as a "major driver." For Fate, the analyst anticipates first-in-man iPSC derived NK cell data on FT500, as well as Phase I study start of FT516 and an investigational new drug filing for FT596 all this year. And for Arvinas, the FDA has cleared the IND for estrogen degrader ARVN-471 and Arvinas will initiate a Phase I study in Q3, Tenthoff tells investors in a research note. He reiterates an Overweight rating on Crispr with a $100 price target, an Overweight rating on Fate with a $30 price target, and an Overweight rating on Arvinas with a $32 price target.
ABCB Ameris Bancorp
$38.74

0.17 (0.44%)

05/15/19
SPHN
05/15/19
NO CHANGE
SPHN
Stephens replaces CenterState with Ameris as 2019 Best Idea
Stephens analyst Tyler Stafford made Ameris Bancorp (ABCB) his new 2019 Best Idea, replacing CenterState Bank (CSFL). Ameris' current valuation is "entirely too cheap" considering its "meaningful tailwinds and favorable outlook" for the remainder of 2019, Stafford tells investors in a research note. The analyst sees the company's "already impressive" profitability profile accelerating even further with the Fidelity Southern (LION) deal. He has an Overweight rating on Ameris with a $52 price target.
07/11/19
RAJA
07/11/19
INITIATION
Target $45
RAJA
Outperform
Ameris Bancorp initiated with an Outperform at Raymond James
Raymond James analyst David Feaster initiated Ameris Bancorp with an Outperform and $45 price target.
01/29/19
RHCO
01/29/19
UPGRADE
Target $48
RHCO
Buy
Ameris Bancorp upgraded to Buy from Hold at SunTrust
SunTrust analyst Jennifer Demba upgraded Ameris Bancorp (ABCB) to Buy and raises her price target to $48 from $36. The analyst notes that the acquisition of Fidelity Southern (LION) announced last month will give it a "significant deposit platform in economically vibrant Atlanta, reduce its cost of funds and further improve efficiency." Demba adds that she is less concerned with the latter's rate of loan growth, noting that although the management targets an expansion of over 10%, it has also promised to maintain the bank's underwriting standards.
01/29/19
RHCO
01/29/19
UPGRADE
RHCO
Buy
Ameris Bancorp upgraded to Buy from Hold at SunTrust
TCBK TriCo Bancshares
$38.52

0.41 (1.08%)

07/09/19
SPHN
07/09/19
DOWNGRADE
Target $40
SPHN
Equal Weight
TriCo Bancshares downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Terry McEvoy downgraded TriCo Bancshares to Equal Weight from Overweight with a $40 price target. The Stephens Bank Research team is now assuming a 25 basis point reduction in the Fed Funds rate in July, September and December 2019 and none in 2020. To reflect his updated estimates, year-to-date stock performance and valuations, McEvoy made a number of rating changes in the Financial Services space.
07/12/19
PIPR
07/12/19
INITIATION
Target $41
PIPR
Neutral
TriCo Bancshares initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Matthew Clark started TriCo Bancshares with a Neutral rating and $41 price target. Consensus estimates for the bank appear too high with its net interest margin outlook more challenged by the flatter curve of late, Clark tells investors in a research note.
AXTA Axalta Coating
$29.40

0.01 (0.03%)

06/21/19
BMOC
06/21/19
NO CHANGE
Target $34
BMOC
Market Perform
Axalta Coating price target raised to $34 from $32 at BMO Capital
BMO Capital analyst John McNulty raised his price target on Axalta Coating to $34 and kept his Market Perform rating following the 15% rally in the stock on news that the management has initiated review of strategic alternatives. The analyst notes that there may be some M&A interest given the company's "attractive" assets, and the stock's fair value could reach the $36-$44 per share range if a deal is reached.
06/20/19
DBAB
06/20/19
NO CHANGE
Target $35
DBAB
Buy
Axalta sale in mid-$30s per share most likely outcome, says Deutsche Bank
Deutsche Bank analyst David Begleiter raised his price target for Axalta Coating Systems (AXTA) to $35 from $30 after the company announced that its board had initiated a review of strategic alternatives, including a potential sale. The analyst views the announcement as a "solid positive," though he notes that it is not new information as Axalta has "arguably" been for sale for the last two-plus years. Further, the timing is unusual as the three most likely bidders for Axalta are somewhat constrained in the near-term as Nippon Paint is buying Dulux, AkzoNobel (AKZOY) is focused on delivering "aggressive" 2020 margin targets, and Sherwin-Williams (SHW) is still a bit levered post Valspar, Begleiter tells investors in a research note. Still, the analyst believes the most likely outcome of Axalta's process is a sale of the company in the mid-$30s per share. And without a sale, Begleiter believes downside in the stock is limited, creating an attractive risk/reward setup. He reiterates a Buy rating on Axalta Coating.
06/26/19
KEYB
06/26/19
NO CHANGE
Target $35
KEYB
Overweight
Axalta Coating price target raised to $35 from $30 at KeyBanc
KeyBanc analyst Michael Sison raised his price target for Axalta Coating to $35 from $30 as it explores strategic alternatives that could yield attractive upside on a takeout basis. On a fundamental basis, the analyst sees modest LSD EBITDA growth driven primarily by pricing and cost savings offsetting weak demand in auto OEM and industrial markets. Sison reiterates an Overweight rating on the shares.
07/12/19
BREN
07/12/19
INITIATION
Target $35
BREN
Buy
Axalta Coating initiated with a Buy at Berenberg
Berenberg analyst Paretosh Misra initiated Axalta Coating with a Buy and $35 price target.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$118.05

-4.78 (-3.89%)

12:18
07/17/19
07/17
12:18
07/17/19
12:18
Downgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 13

    Nov

NSC

Norfolk Southern

$194.90

-11.63 (-5.63%)

12:18
07/17/19
07/17
12:18
07/17/19
12:18
Downgrade
Norfolk Southern rating change  »

Norfolk Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Aug

CSX

CSX

$71.21

-8.36 (-10.51%)

12:18
07/17/19
07/17
12:18
07/17/19
12:18
Downgrade
CSX rating change  »

CSX downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

UNP

Union Pacific

$166.50

-8.6 (-4.91%)

12:17
07/17/19
07/17
12:17
07/17/19
12:17
Downgrade
Union Pacific rating change  »

Union Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
07/17/19
07/17
12:17
07/17/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
07/17/19
07/17
12:16
07/17/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$59.31

0.36 (0.61%)

12:15
07/17/19
07/17
12:15
07/17/19
12:15
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
07/17/19
07/17
12:15
07/17/19
12:15
General news
Breaking General news story  »

Kansas City Federal…

CBB

Cincinnati Bell

$4.28

-0.44 (-9.32%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Cincinnati Bell falls -9.5% »

Cincinnati Bell is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$21.02

-2.08 (-9.00%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Direxion Daily Junior Gold Miners Index Bear 3x Shares falls -9.0% »

Direxion Daily Junior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$38.13

-7.37 (-16.20%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Nu Skin falls -16.0% »

Nu Skin is down -16.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

AG

First Majestic

$9.10

0.53 (6.18%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
First Majestic rises 6.2% »

First Majestic is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$70.17

5.71 (8.86%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Direxion Daily Jr Gld Mnrs Bull 3X Shrs rises 8.7% »

Direxion Daily Jr Gld…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSM

Fortuna Silver Mines

$3.55

0.37 (11.65%)

12:00
07/17/19
07/17
12:00
07/17/19
12:00
Hot Stocks
Fortuna Silver Mines rises 11.6% »

Fortuna Silver Mines is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
07/17/19
07/17
11:55
07/17/19
11:55
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

11:55
07/17/19
07/17
11:55
07/17/19
11:55
Conference/Events
Federal Reserve Bank of Kansas City to speak on economic outlook »

Kansas City Federal…

AVXL

Anavex

$3.03

(0.00%)

11:52
07/17/19
07/17
11:52
07/17/19
11:52
Hot Stocks
Anavex presents new clinical data identifying gut microbiota biomarkers »

Anavex Life Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$11.90

-0.01 (-0.08%)

11:50
07/17/19
07/17
11:50
07/17/19
11:50
Options
Call block in Caesar's noted as account swap from July 8th opener »

Call block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$17.95

-0.48 (-2.60%)

11:45
07/17/19
07/17
11:45
07/17/19
11:45
Options
Mylan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

NTDOY

Nintendo

$0.00

(0.00%)

11:43
07/17/19
07/17
11:43
07/17/19
11:43
Periodicals
Nintendo to launch new Switch model with improved battery life, Kotaku says »

Nintendo plans to release…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

DTEGY

Deutsche Telekom

$0.00

(0.00%)

11:38
07/17/19
07/17
11:38
07/17/19
11:38
Downgrade
Deutsche Telekom rating change at Macquarie »

Deutsche Telekom…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$33.00

-0.29 (-0.87%)

11:36
07/17/19
07/17
11:36
07/17/19
11:36
Hot Stocks
Corning announces new $5B share repurchase authorization »

Corning announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

VRAY

ViewRay

$9.20

0.05 (0.55%)

, EKTAY

Elekta

$0.00

(0.00%)

11:36
07/17/19
07/17
11:36
07/17/19
11:36
Recommendations
ViewRay, Elekta analyst commentary at Jefferies »

Elekta recall a positive…

VRAY

ViewRay

$9.20

0.05 (0.55%)

EKTAY

Elekta

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

FOXA

Fox Corp.

$36.26

-0.41 (-1.12%)

11:35
07/17/19
07/17
11:35
07/17/19
11:35
Options
21st Century Fox put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNC

PNC Financial

$141.24

2.58 (1.86%)

11:31
07/17/19
07/17
11:31
07/17/19
11:31
Hot Stocks
Breaking Hot Stocks news story on PNC Financial »

PNC Financial says sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.